Biomind Labs (Biomind Labs) Dividend Payout Ratio : 0.00 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Biomind Labs Dividend Payout Ratio?

Biomind Labs's dividend payout ratio for the months ended in Sep. 2023 was 0.00.

The historical rank and industry rank for Biomind Labs's Dividend Payout Ratio or its related term are showing as below:

BMNDF's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.44
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-17), the Dividend Yield % of Biomind Labs is 0.00%.

Biomind Labs's Dividends per Share for the months ended in Sep. 2023 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Biomind Labs Dividend Payout Ratio Historical Data

The historical data trend for Biomind Labs's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomind Labs Dividend Payout Ratio Chart

Biomind Labs Annual Data

Trend

Dec21

Dec22

Dividend Payout Ratio

Biomind Labs Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Dividend Payout Ratio	Get a 7-Day Free Trial						-	-	-	-	-

Competitive Comparison of Biomind Labs's Dividend Payout Ratio

For the Biotechnology subindustry, Biomind Labs's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biomind Labs's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomind Labs's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Biomind Labs's Dividend Payout Ratio falls into.

Biomind Labs Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Biomind Labs's Dividend Payout Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2022 )	/	EPS without NRI (A: Dec. 2022 )
	=	0	/	-0.039
	=	N/A

Biomind Labs's Dividend Payout Ratio for the quarter that ended in Sep. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2023 )	/	EPS without NRI (Q: Sep. 2023 )
	=	0	/	-0.002
	=	N/A

Biomind Labs (OTCPK:BMNDF) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Biomind Labs Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Biomind Labs's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomind Labs (Biomind Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomind Labs Inc (OTCPK:BMNDF) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

3XI:Germany BMND:Canada

Address

Camino Saravia s/n, Pando Science and Technology Park, Pando Canelones, Canelones, URY, CP 91.000

Website

https://www.biomindlabs.com

Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.

Biomind Labs (Biomind Labs) Headlines

No Headlines